Bio Preventive Medicine Corp. Statistics
Bio Preventive Medicine Corp. (6810) Stock Statistics & Valuation Metrics
Total Valuation
Bio Preventive Medicine Corp. has a market cap or net worth of TWD 1.09B. The enterprise value is ―.
- Market Cap
- TWD 1.09B
- Enterprise Value
- ―
Share Statistics
Bio Preventive Medicine Corp. has 49,448,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 49,448,500
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Bio Preventive Medicine Corp.’s return on equity (ROE) is -0.32 and return on invested capital (ROIC) is -24.62%.
- Return on Equity (ROE)
- -0.32
- Return on Assets (ROA)
- -0.23
- Return on Invested Capital (ROIC)
- -24.62%
- Return on Capital Employed (ROCE)
- -0.25
- Revenue Per Employee
- 101.04K
- Profits Per Employee
- -3.84M
- Employee Count
- 26
- Asset Turnover
- 0.01
- Inventory Turnover
- 6.57
Valuation Ratios
The current PE Ratio of Bio Preventive Medicine Corp. is -11.03. Bio Preventive Medicine Corp.’s PEG ratio is -0.11.
- PE Ratio
- -11.03
- PS Ratio
- 354.82
- PB Ratio
- 4.18
- Price to FCF
- -11.36
- Price to Operating Cash Flow
- -11.58
- PEG Ratio
- -0.11
Income Statement
In the last 12 months, Bio Preventive Medicine Corp. had revenue of 2.63M and earned -99.85M in profits. Earnings per share was -2.02.
- Revenue
- 2.63M
- Gross Profit
- -4.91M
- Operating Income
- -100.67M
- Pretax Income
- -99.85M
- Net Income
- -99.85M
- EBITDA
- -93.46M
- Earnings Per Share (EPS)
- -2.02
Cash Flow
In the last 12 months, operating cash flow was -93.73M and capital expenditures -1.78M, giving a free cash flow of -95.52M billion.
- Operating Cash Flow
- -93.73M
- Free Cash Flow
- -95.52M
- Free Cash Flow per Share
- -1.93
Dividends & Yields
Bio Preventive Medicine Corp. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -8.80%
- Earnings Yield
- -9.04%
Stock Price Statistics
- Beta
- 0.73
- 52-Week Price Change
- -12.55%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 41.66
- Average Volume (3m)
- 55.49K
Financial Position
Bio Preventive Medicine Corp. as a current ratio of 12.35, with Debt / Equity ratio of 33.10%
- Current Ratio
- 12.35
- Quick Ratio
- 12.30
- Debt to Market Cap
- 0.09
- Net Debt to EBITDA
- 1.59
- Interest Coverage Ratio
- -37.94
Taxes
In the past 12 months, Bio Preventive Medicine Corp. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Bio Preventive Medicine Corp. EV to EBITDA ratio is -10.66, with an EV/FCF ratio of -10.32.
- EV to Sales
- 322.16
- EV to EBITDA
- -10.66
- EV to Free Cash Flow
- -10.32
- EV to Operating Cash Flow
- -10.51
Balance Sheet
Bio Preventive Medicine Corp. has TWD 198.97M in cash and marketable securities with TWD 99.05M in debt, giving a net cash position of TWD 99.92M billion.
- Cash & Marketable Securities
- TWD 198.97M
- Total Debt
- TWD 99.05M
- Net Cash
- TWD 99.92M
- Net Cash Per Share
- TWD 2.02
- Tangible Book Value Per Share
- TWD 5.09
Margins
Gross margin is -134.36%, with operating margin of -3244.88%, and net profit margin of -3209.32%.
- Gross Margin
- -134.36%
- Operating Margin
- -3244.88%
- Pretax Margin
- -3209.32%
- Net Profit Margin
- -3209.32%
- EBITDA Margin
- -3022.26%
- EBIT Margin
- -3244.88%
Analyst Forecast
The average price target for Bio Preventive Medicine Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -73.76%
- EPS Growth Forecast
- -3.76%
